Showing results (361-370 of 379) with videos related to

Sort By:
Pageof 38
Journal of the American Geriatrics Society|November 6, 2007
Association between apolipoprotein E4 and cognitive decline in elderly adultsChris J Packard, Rudi G J Westendorp, David J Stott, et al.
European Heart Journal|September 2, 2021
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis SocietyHenry N Ginsberg, Chris J Packard, M John Chapman, et al.
International Journal of Epidemiology|March 28, 2006
Insight into the nature of the CRP-coronary event association using Mendelian randomizationJuan P Casas, Tina Shah, Jackie Cooper, et al.
European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
European Heart Journal|March 25, 2015
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trialsDavid Preiss, Ross T Campbell, Heather M Murray, et al.
Lancet (London, England)|February 20, 2010
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsNaveed Sattar, David Preiss, Heather M Murray, et al.
Cardiovascular Diabetology|June 6, 2019
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) FoundationJean-Charles Fruchart, Raul D Santos, Carlos Aguilar-Salinas, et al.
European Journal of Preventive Cardiology|December 13, 2016
Genetic invalidation of Lp-PLA<sub>2</sub> as a therapeutic target: Large-scale study of five functional Lp-PLA<sub>2</sub>-lowering allelesJohn M Gregson, Daniel F Freitag, Praveen Surendran, et al.
Nature Communications|March 10, 2015
Genome of The Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levelsElisabeth M van Leeuwen, Lennart C Karssen, Joris Deelen, et al.
Pageof 38